Acetyl Octapeptide-3 NEW
Price | $28 |
Package | 1box |
Min. Order: | 1box |
Supply Ability: | 20000 |
Update Time: | 2024-05-15 |
Product Details
Product Name: Acetyl Octapeptide-3 | CAS No.: 868844-74-0 |
Min. Order: 1box | Purity: 99% |
Supply Ability: 20000 | Release date: 2024/05/15 |
Density 1.6±0.1 g/cm3
Molecular Formula C41H70N16O16S
Molecular Weight 1075.157
Exact Mass 1074.487671
PSA 579.98000
LogP -7.08
Index of Refraction 1.665
Company Profile Introduction
Shanghai Getian Industrial Co.,Ltd is a leading enterprise committed to providing quality products and efficient logistics services. We are proud to introduce a range of products with excellent quality, and the industrial materials are subject to strict quality control to ensure that the high standards of our customers are met.
We have pharmaceutical raw material production factory and reagent research and development center. We now have a complete product line. In addition, we have developed and produced tens of thousands of reagents. We are complemented by a custom synthesis business of various organic compounds. We can synthesize almost any chemical.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$20.00/1kg |
VIP1Y
|
Shandong Deshang Chemical Co., Ltd.
|
2024-08-28 | |
$50.00/1g |
VIP1Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-23 | |
$1.90/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 | |
$0.00/1kg |
VIP1Y
|
Chongqing Zhihe Biopharmaceutical Co., Ltd.
|
2024-05-19 | |
$0.00/1kg |
VIP1Y
|
Shanghai Affida new material science and technology center
|
2024-05-08 | |
$20.00/15mg |
VIP4Y
|
Shanghai UCHEM Inc.
|
2024-04-18 | |
$0.00/1kg |
VIP1Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-08 | |
$30.00/1box |
VIP1Y
|
hebei hongtan Biotechnology Co., Ltd
|
2024-03-20 | |
$55.00/10kg |
VIP1Y
|
Shandong Juchuang Chemical Co., LTD
|
2024-03-11 | |
$300.00/1box |
VIP1Y
|
Hebei Weimiao Import and Export Trade Co., Ltd.
|
2023-12-12 |
- Since: 2024-01-19
- Address: Hong Kong
INQUIRY